Psychiatric News (4/6) reports, “Residential substance use treatment facilities owned by private equity firms are more expensive and may offer fewer services compared with other for-profit facilities, according to a study.” While “using a secret-shopper approach, researchers called 341 residential [substance use disorder] treatment facilities and compared the prices and services of those acquired by private equity firms with those run by other for-profit entities.” The investigators found that “mean daily rates were 15.6% ($127) higher at private equity facilities than at other for-profit facilities.” Additionally, “facilities acquired by private equity firms were less likely to offer detoxification services than other for-profit facilities (74.8% versus 88.8%).” The findings were published in JAMA Health Forum.
Related Links:
— “Private Equity-Run SUD Facilities Are Expensive, but Not Expansive, Psychiatric News , April 6, 2026